On September 5, 2023, Bridge Biotherapeutics, Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
80,900 KRW | +1.13% |
|
+8.16% | +24.46% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.46% | 2.13B | |
+19.27% | 124B | |
+20.13% | 114B | |
+21.14% | 25.83B | |
-24.04% | 19.42B | |
-18.05% | 16.2B | |
-19.22% | 15.31B | |
+55.68% | 14.32B | |
+5.76% | 14.31B | |
-48.79% | 14.19B |
- Stock Market
- Equities
- A141080 Stock
- News LigaChem Biosciences Inc.
- Bridge Biotherapeutics, Inc. announced that it has received KRW 5.9999904 billion in funding from LegoChem Biosciences, Inc.